These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 32674144)
1. Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma. Sasaki T; Katagi H; Goldman S; Becher OJ; Hashizume R Neurosurgery; 2020 Nov; 87(6):E680-E688. PubMed ID: 32674144 [TBL] [Abstract][Full Text] [Related]
2. The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery. Singleton WGB; Bienemann AS; Woolley M; Johnson D; Lewis O; Wyatt MJ; Damment SJP; Boulter LJ; Killick-Cole CL; Asby DJ; Gill SS J Neurosurg Pediatr; 2018 Sep; 22(3):288-296. PubMed ID: 29856296 [TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
4. A combined approach of convection-enhanced delivery of peptide nanofiber reservoir to prolong local DM1 retention for diffuse intrinsic pontine glioma treatment. Bellat V; Alcaina Y; Tung CH; Ting R; Michel AO; Souweidane M; Law B Neuro Oncol; 2020 Oct; 22(10):1495-1504. PubMed ID: 32301996 [TBL] [Abstract][Full Text] [Related]
5. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study. Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805 [TBL] [Abstract][Full Text] [Related]
7. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma. Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR J Neurosurg Pediatr; 2019 Mar; 23(3):333-342. PubMed ID: 30544335 [TBL] [Abstract][Full Text] [Related]
8. Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery. Rechberger JS; Power EA; Lu VM; Zhang L; Sarkaria JN; Daniels DJ Neurosurg Focus; 2020 Jan; 48(1):E2. PubMed ID: 31896090 [TBL] [Abstract][Full Text] [Related]
10. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children. Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851 [TBL] [Abstract][Full Text] [Related]
11. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report. Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124 [TBL] [Abstract][Full Text] [Related]
12. New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model. Louis N; Liu S; He X; Drummond DC; Noble CO; Goldman S; Mueller S; Bankiewicz K; Gupta N; Hashizume R J Neurooncol; 2018 Feb; 136(3):475-484. PubMed ID: 29170909 [TBL] [Abstract][Full Text] [Related]
13. Deformational changes after convection-enhanced delivery in the pediatric brainstem. Bander ED; Tizi K; Wembacher-Schroeder E; Thomson R; Donzelli M; Vasconcellos E; Souweidane MM Neurosurg Focus; 2020 Jan; 48(1):E3. PubMed ID: 31896089 [TBL] [Abstract][Full Text] [Related]
14. Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy. Szychot E; Walker D; Collins P; Hyare H; Shankar A; Bienemann A; Hollingworth M; Gill S Int J Clin Oncol; 2021 Apr; 26(4):647-658. PubMed ID: 33575829 [TBL] [Abstract][Full Text] [Related]
15. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial. McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP J Neurosurg Pediatr; 2021 Oct; 28(4):371-379. PubMed ID: 34359048 [TBL] [Abstract][Full Text] [Related]